PARP1 and cancer: PARP inhibitors (PARPi) exert their effects through synthetic lethality of homologous recombination repair gene defects, such as BRAC, inhibiting DNA damage repair and promoting apoptosis in cancer cells (Slade, 2020; Li et al., 2020).